Additionally, in active MS plaque lesions CXCR2 has been found upon proliferating oligodendrocytes and reactive astrocytes, while its ligand CXCL1 has been associated with activated astrocytes [10], [11]. Here, CXCR2 is linked to myeloid sarcoma.